Ignite Creation Date:
2024-05-05 @ 11:33 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00073879
Status:
COMPLETED
Last Update Posted:
2015-01-29
First Post:
2003-12-10
Brief Title:
Fludarabine Cyclophosphamide and Alemtuzumab in Treating Patients With Recurrent or Metastatic Renal Cell Carcinoma Kidney Cancer Undergoing Allogeneic Stem Cell Transplantation
Sponsor:
Organization:
Baylor College of Medicine